L Schaaf1. Show Affiliations » 1. Max-Planck-Institut fũr Psychiatrie, München. schaaf@mpipsykl.mpg.de
Abstract
Entities: Disease
Mesh： See more » Absorptiometry, PhotonAccidental FallsAgedAnimalsBone DensityBone and Bones/metabolismCross-Sectional StudiesDiabetes Complications/diagnosisDiabetes Complications/drug therapyDiabetes Complications/epidemiologyDiabetes Mellitus, Type 1/diagnosisDiabetes Mellitus, Type 1/drug therapyDiabetes Mellitus, Type 1/epidemiologyDiabetes Mellitus, Type 2/diagnosisDiabetes Mellitus, Type 2/drug therapyDiabetes Mellitus, Type 2/epidemiologyFemaleGlycation End Products, Advanced/metabolismHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useMaleOsteoporotic Fractures/diagnosisOsteoporotic Fractures/epidemiologyRisk Factors
Substances： See more » Glycation End Products, AdvancedHypoglycemic Agents
Year: 2011 PMID： 22165618 DOI： 10.1007/bf03367700
Source DB: PubMed Journal: MMW Fortschr Med ISSN： 1438-3276